Observations placeholder
Afinitor
Identifier
017720
Type of Spiritual Experience
Number of hallucinations: 29
Background
A description of the experience
Everolimus
is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an mTOR (mammalian target of rapamycin) inhibitor. It is currently used as an immunosuppressant to prevent rejection of organ transplants and treatment of renal cell cancer. It is marketed under the tradenames Zortress and Certican in transplantation medicine, and Afinitor in oncology. Everolimus is used in drug-eluting coronary stents as an immunosuppressant to prevent restenosis.
On Dec, 30, 2016 17,448 people reported to have side effects when taking Afinitor. Among them, 29 people (0.17%) have Hallucination
Time on Afinitor when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 75.00% | 25.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Hallucination when taking Afinitor :
| Female | Male | |
| Hallucination | 33.33% | 66.67% |
Age of people who have Hallucination when taking Afinitor :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Hallucination | 0.00% | 0.00% | 0.00% | 0.00% | 33.33% | 0.00% | 33.33% | 33.33% |